Basics Pyxis Oncology, Inc. IPO Date: October 8, 2021 Sector: Healthcare Industry: Biotech Market Cap: $262.75M Activated in VL: True Average Daily Range Avg Daily Range: $0.15 | 4.07% Avg Daily Range (30 D): $0.20 | 4.75% Avg Daily Range (90 D): $0.13 | 4.59% Institutional Daily Volume Avg Daily Volume: .56M Avg Daily Volume (30 D): .7M Avg Daily Volume (90 D): .67M Trade Size Avg Trade Size (Sh.): 164 Avg Trade Size (Sh.) (30 D): 116 Avg Trade Size (Sh.) (90 D): 151 Institutional Trades Total Inst.Trades: 57 Avg Inst. Trade: $1.96M Avg Inst. Trade (30 D): $.73M Avg Inst. Trade (90 D): $.73M Avg Inst. Trade Volume: .57M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $4.68M Avg Closing Trade (30 D): $4.38M Avg Closing Trade (90 D): $4.38M Avg Closing Volume: 1.47M     News Jun 28, 2024 @ 8:30 PM Pyxis Oncology Reports Inducement Grants Under Nas... Source: Pyxis Oncology Jun 10, 2024 @ 11:30 AM Pyxis Oncology Expands Board of Directors with App... Source: Pyxis Oncology May 30, 2024 @ 11:30 AM Pyxis Oncology to Participate in a Fireside Chat a... Source: Pyxis Oncology May 14, 2024 @ 12:40 PM Pyxis Oncology, Inc. (PYXS) Reports Q1 Loss, Tops ... Source: Zacks Equity Research Apr 12, 2024 @ 1:55 PM Does Pyxis Oncology (PYXS) Have the Potential to R... Source: Zacks Equity Research Financials   TTM Q3 2025 Q2 2025 Basic EPS $-1.59 $-.35 $-.3 Diluted EPS $-1.59 $-.35 $-.3 Revenue $ 2.82M $ M $ 2.82M Gross Profit $ $ $ Net Income / Loss $ -97.09M $ -22M $ -18.35M Operating Income / Loss $ -106.19M $ -23.46M $ -19.75M Cost of Revenue $ $ $ Net Cash Flow $ -3.14M $ -1.81M $ -8.74M PE Ratio